Evidence map›Paper›PMID 32912947›Full record

ArticleBMJ open2020

Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk.

Philip Aj Crosbie, Rhian Gabe, Irene Simmonds, Martyn Kennedy, Suzanne Rogerson, Nazia Ahmed, David R Baldwin, Richard Booton, Ann Cochrane, Michael Darby and 13 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03750110 (The Effect of Adding a Personalised Smoking Cessation Intervention to a Lung Cancer Screening Programme), which is not on this map. Cited by 51 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 3 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03750110 nacompletednot on this map

The Effect of Adding a Personalised Smoking Cessation Intervention to a Lung Cancer Screening Programme

TypeinterventionalSponsorUniversity of NottinghamRan2017 to 2022Enrolled1,001ConditionsCancer, Lung, Respiratory Disease, Heart DiseasesArmsIntervention, Usual Care
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 3 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Towards optimized CT lung cancer screening scan protocols.The British journal of radiology · 2026
    Article
  10. Review
  11. Article
  12. Updates in Lung Cancer Screening: A Decade of Evidence.Seminars in respiratory and critical care medicine · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Barriers and Facilitators to Engaging in Smoking Cessation Support Among Lung Screening Participants.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 11 institutions in 1 country.

Philip Aj CrosbieDivision of Infection, Immunity and Respiratory Medicine, The University of Manchester, Manchester, UK.ORCID 0000-0001-8941-4813
Rhian GabeCentre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
Irene SimmondsLeeds Institute of Health Sciences, University of Leeds, Leeds, UK.
Martyn KennedyDepartment of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Suzanne RogersonDepartment of Research and Innovation, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Nazia AhmedLeeds Institute of Health Sciences, University of Leeds, Leeds, UK.
David R BaldwinDepartment of Respiratory Medicine, City Campus, Nottingham University Hospitals, Nottingham, UK.ORCID 0000-0001-8410-7160
Richard BootonLung Cancer and Thoracic Surgery Directorate, Heart and Lung Division, Manchester University NHS Foundation Trust, Manchester, UK.
Ann CochraneYork Trials Unit, Department of Health Sciences, University of York, York, UK.
Michael DarbyDepartment of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Kevin FranksLeeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Sebastian HindeCentre for Health Economics, University of York, York, UK.ORCID 0000-0002-7117-4142
Sam M JanesDepartment of Respiratory Medicine, University College London, London, UK.
Una MacleodHull York Medical School, University of Hull, Hull, UK.
Mike MessengerLeeds Centre for Personalised Medicine and Health, University of Leeds, Leeds, UK.
Henrik MollerThames Cancer Registry, Kings College London, London, UK.
Rachael L MurrayDivision of Epidemiology and Public Health, Faculty of Medicine, University of Nottingham, Nottingham, UK.ORCID 0000-0001-5477-2557
Richard D NealLeeds Institute of Health Sciences, University of Leeds, Leeds, UK.
Samantha L QuaifeResearch Department of Epidemiology and Public Health, University College London, London, UK.
Mark SculpherCentre for Health Economics, University of York, York, UK.
Puvanendran TharmanathanYork Trials Unit, Department of Health Sciences, University of York, York, UK.
David TorgersonYork Trials Unit, Department of Health Sciences, University of York, York, UK.
Matthew Ej CallisterDepartment of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK matthew.callister@nhs.net.
Leeds Teaching Hospitals NHS Trust · GBUniversity of York · GBUniversity of Leeds · GBUniversity College London · GBKing's College London · GBManchester University NHS Foundation Trust · GBNottingham University Hospitals NHS Trust · GBQueen Mary University of London · GBUniversity of Hull · GBUniversity of Manchester · GBUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLung cancer is the world's leading cause of cancer death. Low-dose computed tomography (LDCT) screening reduced lung cancer mortality by 20% in the US National Lung Screening Trial. Here, we present the Yorkshire Lung Screening Trial (YLST), which will address key questions of relevance for screening implementation. METHODS AND ANALYSIS: Using a single-consent Zelen's design, ever-smokers aged 55-80 years registered with a general practice in Leeds will be randomised (1:1) to invitation to a telephone-based risk-assessment for a Lung Health Check or to usual care. The anticipated number randomised by household is 62 980 individuals. Responders at high risk will be invited for LDCT scanning for lung cancer on a mobile van in the community. There will be two rounds of screening at an interval of 2 years. Primary objectives are (1) measure participation rates, (2) compare the performance of PLCO ETHICS AND DISSEMINATION: The study has been approved by the Greater Manchester West research ethics committee (18-NW-0012) and the Health Research Authority following review by the Confidentiality Advisory Group. The results will be disseminated through publication in peer-reviewed scientific journals, presentation at conferences and on the YLST website. TRIAL REGISTRATION NUMBERS: ISRCTN42704678 and NCT03750110.

Indexed as

Lung NeoplasmsQuality of LifeAgedAged, 80 and overEarly Detection of CancerHumansLungMiddle AgedRandomized Controlled Trials as TopicRisk FactorsTomography, X-Ray Computedchest imagingrespiratory tract tumours

Identifiers

PMID32912947
PMCPMC7485242
OpenAlexW3085830165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.